Search Results - "Oporto Espuelas, Macarena"

1

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme by Oporto Espuelas, Macarena, Burridge, Saskia, Kirkwood, Amy A., Bonney, Denise, Watts, Kelly, Shenton, Geoff, Jalowiec, Katarzyna A., O’Reilly, Maeve A., Roddie, Claire, Castleton, Anna, Clesham, Katherine, Nicholson, Emma, Alajangi, Rajesh, Prabhu, Shilpa, George, Lindsay, Uttenthal, Ben, Gabelli, Maria, Neill, Lorna, Besley, Caroline, Chaganti, Sridhar, Wynn, Robert F., Bartram, Jack, Chiesa, Robert, Lucchini, Giovanna, Pavasovic, Vesna, Rao, Anupama, Rao, Kanchan, Silva, Juliana, Samarasinghe, Sujith, Vora, Ajay, Clark, Peter, Cummins, Michelle, Marks, David I., Amrolia, Persis, Hough, Rachael, Ghorashian, Sara

Published in Blood cancer journal (New York) (15-04-2024)

“…CAR T-cell therapy has transformed relapsed/refractory (r/r) B-cell precursor acute lymphoblastic leukaemia (B-ALL) management and outcomes, but following CAR…”
Get full text

Journal Article

2

Practice guideline: Preparation for CAR T‐cell therapy in children and young adults with B‐acute lymphoblastic leukaemia by Mishra, Avijeet Kumar, Burridge, Saskia, Espuelas, Macarena Oporto, O'Reilly, Maeve, Cummins, Michelle, Nicholson, Emma, Wheldon, Sophie, Bonney, Denise, Shenton, Geoff, Marks, David I., Amrolia, Persis J., Hough, Rachael, Ghorashian, Sara

Published in British journal of haematology (01-05-2024)

“…Summary The objective of this guideline, prepared by the ALL subgroup of the Advanced Cell Therapy Sub‐Committee of BSBMTCT (British Society of Blood and…”
Get full text

Journal Article

3

Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial by Peggs, Karl S., Albon, Sarah J., Oporto Espuelas, Macarena, Irving, Catherine, Richardson, Rachel, Casanovas-Company, Joan, Wallace, Rebecca, Guvenel, Aleks, Ghorashian, Sara, Collura, Angela, Subramaniyam, Meera, Flutter, Barry, Popova, Bilyana, Castro, Fernanda, Lopes, Andre, Champion, Kim, Schofield, Oliver, Clifton-Hadley, Laura, Taylor, Thomas, Farrell, Maria, Adams, Stuart, Gilmour, Kimberly C., Mackinnon, Stephen, Tholouli, Eleni, Amrolia, Persis J.

Published in Cytotherapy (Oxford, England) (01-01-2023)

“…Delayed immune reconstitution is a major challenge after matched unrelated donor (MUD) stem cell transplant (SCT). In this randomized phase 2 multi-center…”
Get full text

Journal Article

4

S111: TREATMENT OF POST‐TRANSPLANT RELAPSE IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH BCP ALL USING CD19‐CAR‐T: A EUROPEAN RETROSPECTIVE ANALYSIS OF REAL‐WORLD DATA by Bader, Peter, Alsonso, Anna, Attarbaschi, Andishe, Bodmer, Nicole, Bonig, Halvard, Burridge, Saskia, Bourquin, Jean‐Pierre, Bücklein, Veit, Cario, Gunnar, Oporto Espuelas, Macarena, Feuhtinger, Tobias, Fuereder, Anna, Hauer, Julia, Hutter, Martin, Kałwak, Krzysztof, Künkele, Annette, Meisel, Roland, Mielcarek‐Siedziuk, Monika, Müller, Ingo, Napolitano, Sara, Penack, Olaf, Rives, Susana, Rossig, Claudia, Stackelberg, Arend, Jarisch, Andrea, Ghorashian, Sara, Balduzzi, Adriana

Published in HemaSphere (08-08-2023)

Get full text

Journal Article

5

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL by Ghorashian, Sara, Lucchini, Giovanna, Richardson, Rachel, Nguyen, Kyvi, Terris, Craig, Guvenel, Aleks, Oporto-Espuelas, Macarena, Yeung, Jenny, Pinner, Danielle, Chu, Jan, Williams, Lindsey, Ko, Ka-Yuk, Walding, Chloe, Watts, Kelly, Inglott, Sarah, Thomas, Rebecca, Connor, Christopher, Adams, Stuart, Gravett, Emma, Gilmour, Kimberly, Lal, Alka, Kunaseelan, Sangeetha, Popova, Bilyana, Lopes, Andre, Ngai, Yenting, Hackshaw, Allan, Kokalaki, Evangelia, Carulla, Milena Balasch, Mullanfiroze, Khushnuma, Lazareva, Arina, Pavasovic, Vesna, Rao, Anupama, Bartram, Jack, Vora, Ajay, Chiesa, Robert, Silva, Juliana, Rao, Kanchan, Bonney, Denise, Wynn, Robert, Pule, Martin, Hough, Rachael, Amrolia, Persis J

Published in Blood (11-01-2024)

“…CD19-negative relapse is a leading cause of treatment failure after chimeric antigen receptor (CAR) T-cell therapy for acute lymphoblastic leukemia. We…”
Get full text

Journal Article

6

Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure by Oporto Espuelas, Macarena, Burridge, Saskia, Bonney, Denise, Watts, Kelly, Roddie, Claire, O'Reilly, Maeve A, Shenton, Geoff, Snowden, John A, Furness, Caroline, Jalowiec, Katarzyna Aleksandra Aleksandra, Neill, Lorna, Clesham, Katherine, Nicholson, Emma, Castleton, Anna, Patel, Amit, Besley, Caroline, Wynn, Robert F, Vora, Ajay, Marks, David I., George, Lindsay, Uttenthal, Ben, Chaganti, Sridhar, Cummins, Michelle, Amrolia, Persis J, Hough, Rachael E, Ghorashian, Sara

Published in Blood (15-11-2022)

Get full text

Journal Article

7

ALL Maintenance Treatment for Early Loss of B-Cell Aplasia after Tisagenlecleucel Therapy by Gabelli, Maria, Oporto Espuelas, Macarena, Bonney, Denise, Burridge, Saskia, Farish, Susan, Mullanfiroze, Khushnuma, Lazareva, Arina, Samarasinghe, Sujith, Ancliffe, Philip, Vora, Ajay, Bartram, Jack, Hedges, Emma, Ware, Kirsty, Young, Lindsey, Cugno, Chiara, Chenchara, Lenka, Silva, Juliana, Mirci-Danicar, Oana, Riley, Lynne, Pavasovic, Vesna, Rao, Anupama, Veys, Paul, Lucchini, Giovanna, Chiesa, Robert, Rao, Kanchan, Amrolia, Persis J, Ghorashian, Sara

Published in Blood (23-11-2021)

“…Chimeric antigen receptor (CAR) T-cell therapy is a new, effective treatment for patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukaemia…”
Get full text

Journal Article

8

$Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL$